{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:37:47Z","timestamp":1792787867186,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460157"],"award-info":[{"award-number":["82460157"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["ZK[2024] Major 030"],"award-info":[{"award-number":["ZK[2024] Major 030"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guizhou Provincial Health Commission Science and Technology Foundation","award":["gzwkj2024-147"],"award-info":[{"award-number":["gzwkj2024-147"]}],"id":[{"id":"https:\/\/ror.org\/027yzwq33","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-026-02258-3","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T15:25:08Z","timestamp":1784388308000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Upregulation of osteopontin expression in prostatic stromal cells via the interaction with prostatic epithelial cells contribute to inflammation-related prostatic fibrosis"],"prefix":"10.1186","volume":"26","author":[{"given":"Xing-sheng","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-qi","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-xia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"issue":"1","key":"2258_CR1","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/nau.25078","volume":"42","author":"GZ Fisch","year":"2023","unstructured":"Fisch GZ, Fang AH, Miller CD, Choi C, Monaghan TF, Smith EF, Prishtina L, Weiss JP, Blaivas JG. Polyuria in patients with lower urinary tract symptoms: Prevalence and etiology. NEUROUROL URODYNAM. 2023;42(1):256\u201362.","journal-title":"NEUROUROL URODYNAM"},{"issue":"6","key":"2258_CR2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1097\/JU.0000000000002450","volume":"207","author":"J Akerla","year":"2022","unstructured":"Akerla J, Pesonen JS, Poyhonen A, Koskimaki J, Hakkinen J, Huhtala H, Auvinen A, Tammela TLJ. Lower Urinary Tract Symptoms and Mortality among Finnish Men: The Roles of Symptom Severity and Bother. J Urol. 2022;207(6):1285\u201394.","journal-title":"J Urol"},{"issue":"6","key":"2258_CR3","doi-asserted-by":"publisher","first-page":"glad222","DOI":"10.1093\/gerona\/glad222","volume":"79","author":"AE Adrian","year":"2024","unstructured":"Adrian AE, Liu TT, Pascal LE, Bauer SR, DeFranco DB, Ricke WA. Aging-Related Mitochondrial Dysfunction Is Associated With Fibrosis in Benign Prostatic Hyperplasia. J GERONTOL A-BIOL. 2024;79(6):glad222.","journal-title":"J GERONTOL A-BIOL"},{"issue":"1","key":"2258_CR4","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12964-024-01828-y","volume":"22","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhang C, Feng R, Meng T, Peng W, Song J, Ma W, Xu W, Chen X, Chen J, et al. CXCR4 regulates macrophage M1 polarization by altering glycolysis to promote prostate fibrosis. CELL COMMUN SIGNAL. 2024;22(1):456.","journal-title":"CELL COMMUN SIGNAL"},{"issue":"5","key":"2258_CR5","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1016\/j.asjsur.2024.01.078","volume":"47","author":"J Zhang","year":"2024","unstructured":"Zhang J, Yu C, Li S. Histological inflammation and activation of M2 type macrophages may cause prostate fibrosis. ASIAN J SURG. 2024;47(5):2515\u20136.","journal-title":"ASIAN J SURG"},{"issue":"5","key":"2258_CR6","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.urology.2013.01.053","volume":"81","author":"F Cantiello","year":"2013","unstructured":"Cantiello F, Cicione A, Salonia A, Autorino R, Tucci L, Madeo I, Damiano R. Periurethral fibrosis secondary to prostatic inflammation causing lower urinary tract symptoms: a prospective cohort study. UROLOGY. 2013;81(5):1018\u201323.","journal-title":"UROLOGY"},{"issue":"6","key":"2258_CR7","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1097\/JU.0000000000000385","volume":"202","author":"JA Macoska","year":"2019","unstructured":"Macoska JA, Uchtmann KS, Leverson GE, McVary KT, Ricke WA. Prostate Transition Zone Fibrosis is Associated with Clinical Progression in the MTOPS Study. J Urol. 2019;202(6):1240\u20137.","journal-title":"J Urol"},{"issue":"4","key":"2258_CR8","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.juro.2012.06.007","volume":"188","author":"J Ma","year":"2012","unstructured":"Ma J, Gharaee-Kermani M, Kunju L, Hollingsworth JM, Adler J, Arruda EM, Macoska JA. Prostatic Fibrosis is Associated with Lower Urinary Tract Symptoms. J Urol. 2012;188(4):1375\u201381.","journal-title":"J Urol"},{"issue":"4","key":"2258_CR9","doi-asserted-by":"publisher","first-page":"F817","DOI":"10.1152\/ajprenal.00602.2015","volume":"311","author":"WA Bushman","year":"2016","unstructured":"Bushman WA, Jerde TJ. The role of prostate inflammation and fibrosis in lower urinary tract symptoms. Am J Physiol Renal Physiol. 2016;311(4):F817\u201321.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"5","key":"2258_CR10","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.juro.2016.06.090","volume":"196","author":"JC Nickel","year":"2016","unstructured":"Nickel JC, Roehrborn CG, Castro-Santamaria R, Freedland SJ, Moreira DM. Chronic Prostate Inflammation Is Associated with Severity and Progression of Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Risk of Acute Urinary Retention. J Urol. 2016;196(5):1493\u20138.","journal-title":"J Urol"},{"issue":"9","key":"2258_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11934-019-0917-1","volume":"20","author":"GL Lloyd","year":"2019","unstructured":"Lloyd GL, Marks JM, Ricke WA. Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation? CURR UROL REP. 2019;20(9):54.","journal-title":"CURR UROL REP"},{"issue":"9","key":"2258_CR12","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1046\/j.1464-410x.1999.00352.x","volume":"84","author":"JC NICKEL","year":"1999","unstructured":"NICKEL JC, DOWNEY J, YOUNG I, BOAG S. Asymptomatic inflammation and\/or infection in benign prostatic hyperplasia. BJU INT. 1999;84(9):976\u201381.","journal-title":"BJU INT"},{"issue":"6","key":"2258_CR13","doi-asserted-by":"publisher","first-page":"e100770","DOI":"10.1371\/journal.pone.0100770","volume":"9","author":"L Wong","year":"2014","unstructured":"Wong L, Hutson PR, Bushman W. Prostatic Inflammation Induces Fibrosis in a Mouse Model of Chronic Bacterial Infection. PLoS ONE. 2014;9(6):e100770.","journal-title":"PLoS ONE"},{"issue":"1","key":"2258_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/pros.22886","volume":"75","author":"L Wong","year":"2015","unstructured":"Wong L, Hutson PR, Bushman W. Resolution of chronic bacterial-induced prostatic inflammation reverses established fibrosis. Prostate. 2015;75(1):23\u201332.","journal-title":"Prostate"},{"issue":"18","key":"2258_CR15","doi-asserted-by":"publisher","first-page":"14341","DOI":"10.3390\/ijms241814341","volume":"24","author":"A Mileo","year":"2023","unstructured":"Mileo A, Chianese T, Fasciolo G, Venditti P, Capaldo A, Rosati L, De Falco M. Effects of Dibutylphthalate and Steroid Hormone Mixture on Human Prostate Cells. INT J MOL SCI. 2023;24(18):14341.","journal-title":"INT J MOL SCI"},{"issue":"4\u20135","key":"2258_CR16","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.diff.2011.04.006","volume":"82","author":"TM Nicholson","year":"2011","unstructured":"Nicholson TM, Ricke WA. Androgens and estrogens in benign prostatic hyperplasia: past, present and future. DIFFERENTIATION. 2011;82(4\u20135):184\u201399.","journal-title":"DIFFERENTIATION"},{"issue":"12","key":"2258_CR17","doi-asserted-by":"publisher","first-page":"6291","DOI":"10.1210\/jc.2019-00743","volume":"104","author":"SR Davis","year":"2019","unstructured":"Davis SR, Bell RJ, Robinson PJ, Handelsman DJ, Gilbert T, Phung J, Desai R, Lockery JE, Woods RL, Wolfe RS, et al. Testosterone and Estrone Increase From the Age of 70 Years: Findings From the Sex Hormones in Older Women Study. J CLIN ENDOCR METAB. 2019;104(12):6291\u2013300.","journal-title":"J CLIN ENDOCR METAB"},{"issue":"6","key":"2258_CR18","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s11154-022-09765-2","volume":"23","author":"BD Anawalt","year":"2022","unstructured":"Anawalt BD, Matsumoto AM. Aging and androgens: Physiology and clinical implications. REV ENDOCR METAB DIS. 2022;23(6):1123\u201337.","journal-title":"REV ENDOCR METAB DIS"},{"issue":"3","key":"2258_CR19","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11255-021-03079-z","volume":"54","author":"Y Cao","year":"2022","unstructured":"Cao Y, Tian Y, Zhang H, Luo G, Sun Z, Xia S. Imbalance in the estrogen\/androgen ratio may affect prostate fibrosis through the TGF-beta\/Smad signaling pathway. INT UROL NEPHROL. 2022;54(3):499\u2013508.","journal-title":"INT UROL NEPHROL"},{"issue":"9","key":"2258_CR20","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1007\/s11255-023-03544-x","volume":"55","author":"Y Cao","year":"2023","unstructured":"Cao Y, Zhang H, Tang X, Tu G, Tian Y, Luo G, Wang Y, Wang Z, An L, Luo M, et al. Alterations in the balance of sex hormones may affect rat prostatic inflammation and fibrosis, and osteopontin might be involved in this process. INT UROL NEPHROL. 2023;55(9):2355\u201365.","journal-title":"INT UROL NEPHROL"},{"key":"2258_CR21","doi-asserted-by":"crossref","unstructured":"Lok ZSY, Lyle AN. Osteopontin in Vascular Disease: Friend or Foe? Arteriosclerosis, thrombosis, and vascular biology. 2019;39(4):613\u201322.","DOI":"10.1161\/ATVBAHA.118.311577"},{"issue":"4","key":"2258_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00059-017-4645-3","volume":"44","author":"J Podzimkova","year":"2019","unstructured":"Podzimkova J, Palecek T, Kuchynka P, Marek J, Danek BA, Jachymova M, Kalousova M, Zima T, Linhart A. Plasma osteopontin levels in patients with dilated and hypertrophic cardiomyopathy. HERZ. 2019;44(4):347\u201353.","journal-title":"HERZ"},{"key":"2258_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clinbiochem.2018.07.003","volume":"59","author":"MA Icer","year":"2018","unstructured":"Icer MA, Gezmen-Karadag M. The multiple functions and mechanisms of osteopontin. CLIN BIOCHEM. 2018;59:17\u201324.","journal-title":"CLIN BIOCHEM"},{"issue":"5","key":"2258_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/j.1365-3083.2007.01908.x","volume":"65","author":"J Agnholt","year":"2007","unstructured":"Agnholt J, Kelsen J, Schack L, Hvas CL, Dahlerup JF, S\u00f8rensen ES. Osteopontin, a Protein with Cytokine-like Properties, is Associated with Inflammation in Crohn\u2019s Disease. SCAND J IMMUNOL. 2007;65(5):453\u201360.","journal-title":"SCAND J IMMUNOL"},{"issue":"9","key":"2258_CR25","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1371\/journal.pmed.0020251","volume":"2","author":"A Pardo","year":"2005","unstructured":"Pardo A, Gibson K, Cisneros J, Richards TJ, Yang Y, Becerril C, Yousem S, Herrera I, Ruiz V, Selman M, et al. Up-Regulation and Profibrotic Role of Osteopontin in Human Idiopathic Pulmonary Fibrosis. PLOS MED. 2005;2(9):e251.","journal-title":"PLOS MED"},{"key":"2258_CR26","doi-asserted-by":"publisher","first-page":"111633","DOI":"10.1016\/j.biopha.2021.111633","volume":"139","author":"OF Hatipoglu","year":"2021","unstructured":"Hatipoglu OF, Uctepe E, Opoku G, Wake H, Ikemura K, Ohtsuki T, Inagaki J, Gunduz M, Gunduz E, Watanabe S, et al. Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial\u2013mesenchymal transition. BIOMED PHARMACOTHER. 2021;139:111633.","journal-title":"BIOMED PHARMACOTHER"},{"issue":"1","key":"2258_CR27","first-page":"41","volume":"115","author":"J Surintrspanont","year":"2022","unstructured":"Surintrspanont J. M <>Zhou 2022 Prostate Pathology: What is New in the 2022 WHO Classification of Urinary and Male Genital Tumors? PATHOLOGICA 115 1 41\u201356.","journal-title":"PATHOLOGICA"},{"key":"2258_CR28","doi-asserted-by":"crossref","unstructured":"Silver SV, Popovics P. The Multifaceted Role of Osteopontin in Prostate Pathologies. BIOMEDICINES. 2023;11(11):2895.","DOI":"10.3390\/biomedicines11112895"},{"key":"2258_CR29","doi-asserted-by":"publisher","first-page":"115384","DOI":"10.1016\/j.taap.2020.115384","volume":"411","author":"J Chen","year":"2021","unstructured":"Chen J, Rong N, Liu M, Xu C, Xiong Q, Lei Y. The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. TOXICOL APPL PHARM. 2021;411:115384.","journal-title":"TOXICOL APPL PHARM"},{"issue":"6","key":"2258_CR30","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/s41416-022-02085-x","volume":"128","author":"F Pederzoli","year":"2023","unstructured":"Pederzoli F, Raffo M, Pakula H, Ravera F, Nuzzo PV, Loda M. Stromal cells in prostate cancer pathobiology: friends or foes? BRIT J CANCER. 2023;128(6):930\u20139.","journal-title":"BRIT J CANCER"},{"key":"2258_CR31","doi-asserted-by":"publisher","first-page":"1395596","DOI":"10.3389\/fimmu.2024.1395596","volume":"15","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Huang Z, Gao L, Ma H, Chang R. Osteopontin\/SPP1: a potential mediator between immune cells and vascular calcification. FRONT IMMUNOL. 2024;15:1395596.","journal-title":"FRONT IMMUNOL"},{"issue":"4","key":"2258_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2024.5413","volume":"54","author":"X Yang","year":"2024","unstructured":"Yang X, Liu Z, Zhou J, Guo J, Han T, Liu Y, Li Y, Bai Y, Xing Y, Wu J, et al. SPP1 promotes the polarization of M2 macrophages through the Jak2\/Stat3 signaling pathway and accelerates the progression of idiopathic pulmonary fibrosis. INT J MOL MED. 2024;54(4):1.","journal-title":"INT J MOL MED"},{"issue":"6","key":"2258_CR33","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/j.1939-4640.1992.tb00338.x","volume":"13","author":"GR Cunha","year":"1992","unstructured":"Cunha GR, Alarid ET, Turner T, Donjacour AA, Boutin EL, Foster BA. Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors. J Androl. 1992;13(6):465\u201375.","journal-title":"J Androl"},{"issue":"3","key":"2258_CR34","first-page":"154","volume":"10","author":"KJ Gangavarapu","year":"2022","unstructured":"Gangavarapu KJ, Jowdy PF, Foster BA, Huss WJ. Role of prostate stem cells and treatment strategies in benign prostate hyperplasia. AM J CLIN EXP UROL. 2022;10(3):154\u201369.","journal-title":"AM J CLIN EXP UROL"},{"issue":"7","key":"2258_CR35","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41573-025-01158-9","volume":"24","author":"F Rieder","year":"2025","unstructured":"Rieder F, Nagy LE, Maher TM, Distler JHW, Kramann R, Hinz B, Prunotto M. Fibrosis: cross-organ biology and pathways to development of innovative drugs. Nat Rev Drug Discov. 2025;24(7):543\u201369.","journal-title":"Nat Rev Drug Discov"},{"issue":"13","key":"2258_CR36","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.7150\/ijbs.86492","volume":"19","author":"E Mart\u00edn-V\u00e1zquez","year":"2023","unstructured":"Mart\u00edn-V\u00e1zquez E, Cobo-Vuilleumier N, L\u00f3pez-Noriega L, Lorenzo PI, Gauthier BR. The PTGS2\/COX2-PGE 2 signaling cascade in inflammation: Pro or anti? A case study with type 1 diabetes mellitus. INT J BIOL SCI. 2023;19(13):4157\u201365.","journal-title":"INT J BIOL SCI"},{"issue":"8","key":"2258_CR37","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.3390\/ijms23084205","volume":"23","author":"J Korbecki","year":"2022","unstructured":"Korbecki J, G\u0105ssowska-Dobrowolska M, W\u00f3jcik J, Szatkowska I, Barczak K, Chlubek M, Baranowska-Bosiacka I. The Importance of CXCL1 in Physiology and Noncancerous Diseases of Bone, Bone Marrow, Muscle and the Nervous System. Int J Mol Sci. 2022;23(8):4205.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2258_CR38","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1002\/mco2.147","volume":"3","author":"H Li","year":"2022","unstructured":"Li H, Wu M, Zhao X. Role of chemokine systems in cancer and inflammatory diseases. MEDCOMM. 2022;3(2):e147.","journal-title":"MEDCOMM"},{"issue":"12","key":"2258_CR39","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.3390\/cells8121558","volume":"8","author":"I Abdelaziz Mohamed","year":"2019","unstructured":"Abdelaziz Mohamed I, Gadeau A, Hasan A, Abdulrahman N, Mraiche F. Osteopontin: A Promising Therapeutic Target in Cardiac Fibrosis. CELLS-BASEL. 2019;8(12):1558.","journal-title":"CELLS-BASEL"},{"issue":"1","key":"2258_CR40","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1186\/s12967-023-04279-0","volume":"21","author":"J Ji","year":"2023","unstructured":"Ji J, Zheng S, Liu Y, Xie T, Zhu X, Nie Y, Shen Y, Han X. Increased expression of OPN contributes to idiopathic pulmonary fibrosis and indicates a poor prognosis. J TRANSL MED. 2023;21(1):640.","journal-title":"J TRANSL MED"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-026-02258-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02258-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02258-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:49:52Z","timestamp":1791964192000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-026-02258-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2258"],"URL":"https:\/\/doi.org\/10.1186\/s12894-026-02258-3","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki. The data and biological materials used in this study were obtained from research specimens collected during the clinical diagnosis and treatment of patients at Guizhou Provincial People\u2019s Hospital (exempted from informed consent). The study does not involve the collection of subject privacy data and will not have adverse effects on the rights and health of the subjects. Prior to analysis, the patients\u2019 identity information was anonymized and de-identified. This study was approved by the Ethics Committee of Human Medical Experiments at Guizhou University (HMEE-GZU-2022-T005).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"243"}}